An adiponectin receptor agonist promote osteogenesis via regulating bone‐fat balance
OBJECTIVES: Adiponectin signalling has been considered to be a promising target to treat diabetes‐related osteoporosis. However, contradictory results regarding bone formation were observed due to the various isoforms of adiponectin. Therefore, it would be necessary to investigate the effect of adip...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168410/ https://www.ncbi.nlm.nih.gov/pubmed/33939201 http://dx.doi.org/10.1111/cpr.13035 |